AI-generated summary
The authors randomized 52 patients with melasma to either 532-nm or 1,064-nm Q-switched Nd:YAG laser toning over eight sessions and compared outcomes. They report that the 532-nm laser produced significantly greater improvement in the MASI score and more very satisfied responses, while the two groups did not differ in pain or recurrence. The authors describe the 532-nm laser as effective and safe, though the abstract notes the 1,064-nm laser performed better for skin rejuvenation.
- Participants
- 52
- Who or what was studied
- Patients with melasma and facial photoaging
- Wavelengths
- 532 nm
- Limits stated in the abstract
- The abstract does not describe the study's follow-up length beyond a 2-month visit or how recurrence was measured, and it reports results for a single-center randomized trial of 52 patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.